Bone metastases and breast cancer.

[1]  M. Anliker,et al.  Bone loss in premenopausal and postmenopausal women. A cross-sectional and longitudinal study using quantitative computed tomography. , 1984, The Journal of bone and joint surgery. American volume.

[2]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.

[3]  E. Canalis,et al.  Direct stimulation of bone resorption by epidermal growth factor. , 1980, Endocrinology.

[4]  O. Bijvoet,et al.  INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.) , 1979, The Lancet.

[5]  C. Danjoux,et al.  The acute radiation syndrome , 1979 .

[6]  L. Delclos,et al.  Palliative Irradiation in Breast Cancer , 1964 .

[7]  G. Mundy,et al.  Relation of Osteoclast Activating Factor Production to Extent of Bone Disease in Multiple Myeloma , 1981, British journal of haematology.

[8]  O. V. Batson.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES , 1940, Annals of surgery.

[9]  T. Żebro,et al.  PROSTAGLANDINS AND BREAST CANCER , 1977, The Lancet.

[10]  A. Glicksman,et al.  Single-dose radiation therapy in the palliation of metastatic disease. , 1969, Radiology.

[11]  P. Fitzpatrick,et al.  Radiation pneumonitis: experience following a large single dose of radiation. , 1978, International journal of radiation oncology, biology, physics.

[12]  A. Y. Foo,et al.  Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. , 1984, Clinical chemistry.

[13]  D. Amadori,et al.  Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer: A prospective randomized study , 1983, Cancer.

[14]  C. Galasko,et al.  Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits. , 1979, British Journal of Cancer.

[15]  S. Mergenhagen,et al.  Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood Leukocytes , 1972, Science.

[16]  C. Blomqvist,et al.  LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES , 1983, The Lancet.

[17]  C. Mundy,et al.  Direct resorption of bone by human monocytes. , 1977, Science.

[18]  P. Ward,et al.  Chemotactic responses of tumor cells to products of resorbing bone. , 1979, Science.

[19]  C. Galasko.  The pathological basis for skeletal scintigraphy. , 1972, The Journal of bone and joint surgery. British volume.

[20]  Bourdillon Jf.  IMMUNISATION AGAINST MEASLES. , 1964 .

[21]  J. Oates,et al.  Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. , 1975, The New England journal of medicine.

[22]  A. Cats,et al.  In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation. , 1982, Immunology.

[23]  S. George,et al.  Prognostic factors in the initial response to therapy by patients with advanced breast cancer. , 1978, Journal of the National Cancer Institute.

[24]  C. Galasko.  Mechanisms of bone destruction in the development of skeletal metastases , 1976, Nature.

[25]  D. Rowe,et al.  Collagen and collagen-derived fragments are chemotactic for tumor cells. , 1981, The Journal of clinical investigation.

[26]  M. Tattersall,et al.  Advanced breast cancer: response to high dose oral medroxyprogesterone acetate. , 1984, Australian and New Zealand journal of medicine.

[27]  R. K. Beals,et al.  Prophylactic internal fixation of the femur in metastatic breast cancer , 1971, Cancer.

[28]  J. Kanis,et al.  INTRAVENOUS CLODRONATE IN THE TREATMENT AND RETREATMENT OF PAGET'S DISEASE OF BONE , 1985, The Lancet.

[29]  J. Stephenson,et al.  Human transforming growth factors induce tyrosine phosphorylation of EGF receptors , 1981, Nature.

[30]  R. Santen,et al.  Comparison of surgical adrenalectomy to medical adrenalectomy in patients with metastatic carcinoma of the breast. , 1982, Cancer research.

[31]  H. Fleisch,et al.  Increase in alkaline phosphatase activity in calvaria cells cultured with diphosphonates. , 1979, The Biochemical journal.

[32]  A. Manni,et al.  Antihormone treatment of stage IV breast cancer , 1979, Cancer.

[33]  G. Mundy,et al.  Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor. , 1981, The Journal of clinical investigation.

[34]  H. Antoniades,et al.  Platelet-derived growth factor stimulates bone resorption via a prostaglandin-mediated mechanism. , 1982, Endocrinology.

[35]  T. Powles,et al.  The Inhibition by Aspirin and Indomethacin of Osteolytic Tumour Deposits and Hypercalcaemia in Rats with Walker Tumour, and its Possible Application to Human Breast Cancer , 1973, British Journal of Cancer.

[36]  T. Powles,et al.  Assessment of response of bone metastases to systemic treatment in patients with breast cancer , 1983, Cancer.

[37]  G. Palmieri,et al.  The Postabsorptive Hydroxyproline in the Long‐Term Evaluation of Patients With Breast Cancer , 1983, Cancer.

[38]  G. Mundy,et al.  Bone-resorbing activity in supernatants from lymphoid cell lines. , 1974, The New England journal of medicine.

[39]  P. Meunier,et al.  Effects of disodium dichloromethylene diphosphonate on bone loss in paraplegic patients. , 1981, The Journal of clinical investigation.

[40]  C. D. HAAGENSEN,et al.  Diseases of the Breast , 1972 .

[41]  G. Mundy,et al.  Effect of osteoclast activating factor from human leukocytes on bone metabolism. , 1975, The Journal of clinical investigation.

[42]  M. Tattersall,et al.  Hypercalcaemia after tamoxifen for breast cancer: a sign of tumour response? , 1979, British medical journal.

[43]  L. Yam.  Clinical significance of the human acid phosphatases: a review. , 1974, The American journal of medicine.

[44]  R. Milch,et al.  Response of bone to tumor invasion , 1956, Cancer.

[45]  F. Cavalli,et al.  Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  I. Macdonald.  Endocrine ablation in disseminated mammary carcinoma. , 1962, Surgery, gynecology & obstetrics.

[47]  G. Mundy,et al.  Direct resorption of bone by human breast cancer cells in vitro , 1978, Nature.

[48]  B. Kream,et al.  Regulation of bone formation. , 1983, The New England journal of medicine.

[49]  R. K. Knight,et al.  Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer. , 1982, European journal of cancer & clinical oncology.

[50]  R. K. Knight,et al.  Corticosteroids for elderly patients with breast cancer , 1981, Cancer.

[51]  J. Wiener,et al.  Survival of patients with metastatic breast cancer treated with either combination or sequential chemotherapy. , 1979, Cancer research.

[52]  H. Fleisch.  Bisphosphonates : Mechanisms of Action and Clinical Applications , 1983 .

[53]  S. Jones,et al.  Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancer , 1975, Cancer.

[54]  D. Moss,et al.  Improved electrophoretic resolution of bone and liver alkaline phosphatases resulting from partial digestion with neuraminidase. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[55]  F. Pannuti,et al.  A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate. , 1978, Cancer treatment reports.

[56]  Kimbroe J. Carter,et al.  The cellular basis of metastatic bone disease in patients with lung cancer , 1981, Cancer.

[57]  M. Rossleigh,et al.  The assessment of response to therapy of bone metastases in breast cancer. , 1984, Australian and New Zealand journal of medicine.

[58]  M. Silverstein,et al.  Bilateral adrenalectomy for advanced breast cancer: a 21 year experience. , 1975, Surgery.

[59]  C S Galasko,et al.  Mechanisms of lytic and blastic metastatic disease of bone. , 1982, Clinical orthopaedics and related research.

[60]  T. Powles,et al.  BREAST-CANCER OSTEOLYSIS, BONE METASTASES, AND ANTI-OSTEOLYTIC EFFECT OF ASPIRIN , 1976, The Lancet.

[61]  B. Stoll,et al.  Serial Quantitative Bone Scanning of Metastatic Tumour in Rats , 1980 .

[62]  C. Osborne,et al.  Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. , 1983, Science.

[63]  G. G. Winzelberg,et al.  Focal left ventricular dyskinesis. , 1984, Seminars in nuclear medicine.

[64]  R. Coombes,et al.  Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours. , 1974, Lancet.

[65]  L. Whitby,et al.  A simplified heat-inactivation method for investigating alkaline phosphatase isoenzymes in serum. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[66]  A. Johnston.  Pathology of Metastatic Tumors in Bone , 1970, Clinical orthopaedics and related research.

[67]  G. Mundy,et al.  Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy. , 1978, The American journal of medicine.

[68]  B. Mertens,et al.  New diagnostic use of bone marrow acid and alkaline phosphatase. , 1976, American journal of clinical pathology.

[69]  L. Deftos,et al.  New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. , 1980, The Journal of clinical investigation.

[70]  P. Reitsma,et al.  A new diphosphonate: dissociation between effects on cells and mineral in rats and a preliminary trial in Paget's disease. , 1978, Advances in experimental medicine and biology.

[71]  H. Mouridsen,et al.  Tamoxifen in advanced breast cancer. , 1978, Cancer treatment reviews.

[72]  B. Kream,et al.  Regulation of bone formation (second of two parts). , 1983, The New England journal of medicine.

[73]  A. Tashjian,et al.  Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvaria. , 1978, Biochemical and biophysical research communications.

[74]  E. Borden,et al.  Further clinical studies with megestrol acetate in advanced breast cancer , 1976, Cancer.

[75]  R. Buchanan,et al.  A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd. , 1984, British Journal of Cancer.

[76]  T. Powles,et al.  In vitro osteolytic activity of human breast carcinoma tissue and prognosis. , 1981, British Journal of Cancer.

[77]  J. Greiff.  Autoradiographic studies of fracture healing using 99Tcm-Sn-polyphosphate. , 1978, Injury.

[78]  S Krauss,et al.  A comparison of cyclophosphamide, adriamycin, 5‐fluorouracil (CAF) and cyclophosphamide, methotrexate, 5‐fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer. A southeastern cancer study group project , 1977, Cancer.

[79]  P. Rubin,et al.  Nonunion of pathologic fracture after radiation therapy. , 1967, Radiology.

[80]  J. Body,et al.  Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man. , 1983, The Journal of clinical endocrinology and metabolism.

[81]  H. Kleinman,et al.  Osteonectin, a bone-specific protein linking mineral to collagen , 1981, Cell.

[82]  A. Wambersie,et al.  The influence of cell proliferation in tumours and normal tissues during fractionated radiotherapy. , 1971, European journal of cancer.

[83]  G. T. Krishnamurthy,et al.  Distribution pattern of metastatic bone disease. A need for total body skeletal image. , 1977, JAMA.

[84]  R. Blamey,et al.  Calcium excretion (CaE) in metastatic breast cancer , 1983, The British journal of surgery.

[85]  P. Meunier,et al.  Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. , 1984, Cancer research.

[86]  R. K. Knight,et al.  Norethisterone acetate in the treatment of advanced breast cancer. , 1976, Clinical oncology.

[87]  L. Trodella,et al.  Pain in osseous metastases: Results of radiotherapy , 1984, Pain.

[88]  A. Jung.  Comparison of two parenteral diphosphonates in hypercalcemia of malignancy. , 1982, The American journal of medicine.

[89]  S. Ralston,et al.  FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE , 1984, The Lancet.

[90]  B. A. Goddard,et al.  Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging. , 1981, The British journal of radiology.

[91]  F. Chu,et al.  The effectiveness of radiation therapy in the treatment of bone metastases from breast cancer. , 1978, Radiology.

[92]  B. McNeil.  Value of bone scanning in neoplastic disease. , 1984, Seminars in nuclear medicine.

[93]  R. Rubens,et al.  Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. , 1981, European journal of cancer.

[94]  S. Pocock,et al.  Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L‐phenylalanine mustard , 1976, Cancer.

[95]  H. Sleeboom,et al.  COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIA , 1983, The Lancet.